Identification and Characterization of the Chlamydia trachomatis L2 S-Adenosylmethionine Transporter by Binet, Rachel et al.
Identiﬁcation and Characterization of the Chlamydia trachomatis L2
S-Adenosylmethionine Transporter
Rachel Binet, Reinaldo E. Fernandez, Derek J. Fisher, and Anthony T. Maurelli
Department of Microbiology and Immunology, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
ABSTRACT Methylationisessentialtothephysiologyofallcells,includingtheobligateintracellularbacterium Chlamydia.Never-
theless, the methylation cycle is under strong reductive evolutionary pressure in Chlamydia. Only Parachlamydia acanthamoe-
bae and Waddlia chondrophila genome sequences harbor homologs to metK, encoding the S-adenosylmethionine (SAM) syn-
thetaserequiredforsynthesisofSAM,andto sahH,whichencodestheS-adenosylhomocysteine(SAH)hydrolaserequiredfor
detoxiﬁcationofSAHformedafterthetransferofthemethylgroupfromSAMtothemethylationsubstrate.Transformationofa
conditional-lethal metK mutant of Escherichia coli with a genomic library of Chlamydia trachomatis L2 identiﬁed CTL843 as a
putativeSAMtransporterbasedonitsabilitytoallowthemutanttosurvive metKdeﬁciencyonlyinthepresenceofextracellular
SAM. CTL843 belongs to the drug/metabolite superfamily of transporters and allowed E. coli to transport S-adenosyl-L-[methyl-
14C]methioninewithanapparentKmof5.9MandaVmaxof32pmolmin1mg1.Moreover,CTL843conferredagrowthad-
vantage to a pfs E. coli mutant that lost the ability to detoxify SAH, while competition and back-transport experiments further
impliedthatSAHwasanadditionalsubstrateforCTL843.WeproposethatCTL843actsasaSAM/SAHtransporter(SAMHT)
servingadualfunctionbyallowing ChlamydiatoacquireSAMfromthehostcellandexcretethetoxicby-productSAH.The
demonstrationofafunctionalSAMHTprovidesfurtherinsightintothereductiveevolutionassociatedwiththeobligateintra-
cellularlifestyleofChlamydiaandidentiﬁesanexcellentchemotherapeutictarget.
IMPORTANCE Obligateintracellularparasiteslike Chlamydiahavefollowedareductiveevolutionarypaththathasmadethem
almosttotallydependentontheirhostcellfornutrients.Inthiswork,weidentifyauniquetransporterofametaboliteessential
forallmethylationreactionsthatpotentiallybypassestheneedfortwoenzymaticreactionsin Chlamydia.Thetransporter,
CTL843, allows Chlamydia trachomatis L2 to steal S-adenosylmethionine (SAM) from the eukaryotic host cytosol and to likely
removethetoxicS-adenosylhomocysteine(SAH)formedwhenSAMlosesitsmethylgroup,actingasaSAM/SAHtransporter
(SAMHT).Inadditiontoreﬂectingtheadaptationof Chlamydiatoanobligateintracellularlifestyle,thespeciﬁcandcentral
rolesofSAMHTinChlamydiametabolismprovideatargetforthedevelopmentoftherapeuticagentsforthetreatmentofchla-
mydialinfections.
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C
hlamydiaeliveasobligateintracellularparasitesinspecialized
vacuoles within eukaryotic cells. The vast majority of species
within this phylum of Gram-negative bacteria cause diseases in
animals and/or humans and belong to the genus Chlamydia, al-
though the list of Chlamydia-like organisms capable of causing
disease continues to expand (1). Chlamydia trachomatis causes
severe ocular and urogenital infections in humans and was the
ﬁrst Chlamydia species to be fully sequenced (2). Since that time,
the sequences of 26 additional chlamydial genomes have been
released in public databases (http://www.ncbi.nlm.nih.gov
/genomes/MICROBES/microbial_taxtree.html). All chlamydiae
show signs of incomplete biosynthetic pathways, similar to other
organismsthathaveadaptedtoparasitic/symbioticlifestyles,such
as mycoplasmas, phytoplasmas, and alpha- and gammaproteo-
bacteria, including rickettsiae. Although novel enzymes have
evolvedtobypasssomeofthesemetabolic“holes”(3),thereduced
genome size of obligate intracellular organisms is possible mostly
because many metabolites do not need to be synthesized by the
complexpathwayscharacteristicoffree-livingbacteriabutinstead
are transported from the substrate-rich host cell cytoplasm by
novel transport systems absent in free-living bacteria (4). For ex-
ample, a speciﬁc nucleotide transport protein allows Protochla-
mydia amoebophila to acquire the universal electron carrier NAD
(NAD)fromthehostinexchangeforbacterialADP,ratherthan
synthesizing this compound (5).
S-Adenosyl-L-methionine (also known as AdoMet or SAM) is
an essential intermediate in the physiology of all cells (6). The
majority of SAM is used for methyltransferase reactions in which
the S-methyl group of SAM is transferred to acceptor substrates,
including nucleic acids, proteins, phospholipids, biological
amines, and a long list of small molecules. During the transmeth-
ylation reaction, SAM is converted to S-adenosylhomocysteine
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group.SAHisapotentinhibitorofSAM-dependentmethyltrans-
ferases and is therefore rapidly detoxiﬁed either by a SAH hydro-
laseorbyamethylthioadenosine(MTA)/SAHnucleosidase(7,8).
AlthoughSAMisnotlikelytobeusedasamethylgroupdonorfor
DNAinChlamydiaduetotheabsenceofDNAmethyltransferases
(9), we recently showed that methylation of C. trachomatis 16S
rRNA by the bacterial KsgA methylase is critical for bacterial ﬁt-
ness (10), conﬁrming an earlier report that SAM-dependent
methylation reactions take place in chlamydiae (11).
Inthisstudy,weexaminedthemethylationcycleinChlamydia.
Comparative genome analysis showed that the methylation cycle
is under reductive evolutionary pressure in Chlamydia. Only two
Chlamydia-like organisms, Parachlamydia acanthamoebae and
Waddlia chondrophila, appear to possess both an
S-adenosylmethioninesynthetase,theconservedbutenergetically
demanding enzyme that catalyzes the only known route of SAM
synthesis(12),andarecognizedSAHcatabolizingenzyme.Dueto
the lack of genetic tools for manipulating chlamydiae, we used
Escherichia coli as a surrogate host to identify the strategy em-
ployed by the majority of chlamydiae to acquire SAM and elimi-
nate SAH. By use of C. trachomatis serovar L2 strain 434/Bu as a
model, CTL843 was identiﬁed through a genetic screen in a SAM
synthetase-deﬁcient E. coli strain and shown to mediate transport
of SAM and likely SAH, acting as a SAMHT (SAM/SAH trans-
porter). While serving as another example of the specialization of
Chlamydiawithinitseukaryoticcellniche,thediscoveryofanovel
means of Chlamydia host-cell interaction also presents an excel-
lent chemotherapeutic target for the treatment of chlamydial in-
fections.
RESULTS
Themethylationcycleisunderreductiveevolutionarypressure
in Chlamydia. We recently showed that the conserved dimethyl-
transferase KsgA plays an important role in Chlamydia biology
(10).KsgAtransferstwomethylgroupsfromtheactivatedmethyl
donor SAM to the 16S rRNA molecules in ribosomes, generating
the toxic by-product SAH. S-Adenosylmethionine synthetase
(MATorAdoMetsynthetase[EC2.5.1.6])istheenzymethatsyn-
thesizes SAM from methionine and ATP. MAT is a highly con-
served protein that is well studied at the primary, secondary, and
tertiary structural levels and is an essential enzyme in prokaryotes
and eukaryotes (12, 13). Comparative analysis of Chlamydia ge-
nome sequences identiﬁed open reading frames (ORFs) sharing
60% identity with E. coli MAT in P. acanthamoebae and W. chon-
drophila (i.e., pah_c014o152 and wcw_0127, respectively) and
harboringalltheconservedaminoacidresiduesrequiredforSAM
synthetase activity (see Fig. S1 in the supplemental material). On
the other hand, no MAT homolog was found in the other chla-
mydial genome sequences available (as of March 2011), with the
exception of P. amoebophila, where a gene encoding a truncated
and likely nonfunctional version of MAT (i.e., Pc1819) was iden-
tiﬁed.
Because SAH formed from SAM during methylation reactions
needstobeeliminatedduetoitsinhibitoryeffectonmethyltrans-
ferases,wealsolookedforthepresenceofgenesencodingputative
SAH-detoxifying enzymes in Chlamydia genome sequences. Two
different classes of enzymes degrade SAH in living cells. Most
microbes, including E. coli, harbor an MTA/SAH nucleosidase
(MTAN; EC 3.2.2.9) to metabolize SAH to adenine and
S-ribosylhomocysteine, whereas mammals and some microbes
employ a speciﬁc SAH hydrolase (SahH) (EC 3.3.1.1) to metabo-
lize SAH into homocysteine and adenosine. Although putative
MTAN ORFs are identiﬁed in the genome annotation of Chla-
mydia felis (i.e., CF0410), Chlamydia caviae (i.e., CCA0593), and
Chlamydia pneumoniae (i.e., Cpn0232 for C. pneumoniae TW-
183), sequence alignments revealed that most of the conserved
residues required for MTAN activity in Arabidopsis thaliana,
E.coli,andStaphylococcusaureusweremissinginthesechlamydial
homologs (Fig. S2). Further examination revealed that the prod-
ucts of these three chlamydial ORFs belong to the PNP_UDP_1
superfamily (PF01048), which includes purine nucleoside phos-
phorylase (PNP), uridine phosphorylase (UdRPase), and 5=-
methylthioadenosine phosphorylase (MTA phosphorylase).
Thus, they are unlikely to be involved in SAH hydrolysis. Consis-
tent with the presence of MAT in P. acanthamoebae and W. chon-
drophila, SahH homologs possessing the conserved motifs repre-
sentative of active SahH enzymes were identiﬁed in these
organisms, i.e., pah_c022o240 and wcw_1005, respectively
(Fig. S3). Since out of 26 chlamydial genomes analyzed, only two,
P. acanthamoebae and W. chondrophila, appear to have the genes
for a complete methylation cycle (SAM synthesis, methylation
activity, and SAH detoxiﬁcation), the question is raised as to how
the majority of Chlamydia species (which all possess at least one
SAM-utilizingenzyme),includingC.trachomatis,synthesizeSAM
and detoxify SAH.
Positive selection of C. trachomatis L2 metK-
complementing ORF in E. coli. metK is essential in E. coli, and E.
coli cells are impermeable to extracellular SAM (14–16). To con-
struct a conditional-lethal metK mutant of E. coli, the rescuing
copy of metK needs to be tightly controlled. Although metK dele-
tion was ﬁrst obtained in ATM770 (Table 1), this strain was still
able to grow in the absence of IPTG (isopropyl--D-
thiogalactopyranoside),indicatingthatthelactosepromotercon-
trolling metK in pREF71 was still leaky in the absence of inducer
(data not shown), as previously encountered with the ara pro-
moter(16).Ontheotherhand,byplacementofacopyofthemetK
gene containing an alternate GUG start codon (to reduce transla-
tional efﬁciency) under the control of the arabinose-inducible,
glucose-repressible ara promoter, the growth and/or survival of
themetKATM778mutantwasmadedependentonthepresence
of arabinose (Fig. 1A). We screened a C. trachomatis serovar L2
genomic DNA library in ATM778 in the presence of glucose and
identiﬁed several colonies on medium supplemented with 1 mM
SAM, while no colonies were detected under the same conditions
in the absence of extracellular SAM. Two of 12 independent col-
onies characterized displayed consistent SAM-dependent growth
in the presence of glucose (i.e., repression of E. coli metK expres-
sion) (Fig. 1B). Rescuing plasmids were isolated and analyzed by
restriction mapping and sequence analyses. All library clones re-
vealed the same 2,528-bp insert harboring C. trachomatis L2
CTL843and123bpofupstreamsequenceinthesameorientation
as the lactose promoter of pUC, followed by CTL842 with 7 bp of
upstream sequence, in reverse orientation. Subcloning of this
ORF into pBluescript (i.e., pRAK368, Table 1) conﬁrmed that
CTL843 conferred a SAM-dependent growth phenotype to
ATM778inthepresenceofglucoseandIPTG(Fig.1B),suggesting
that CTL843 functions as a transporter for SAM.
Kinetic analysis of SAM uptake in whole cells expressing re-
combinant CTL843. To investigate CTL843 function, uptake of
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tion assay. Control cells showed a slow, low linear uptake of SAM
(Fig.2A).Incontrast,expressionofCTL843inATM915showeda
markedincreaseintheamountofintracellularlabelovertimeina
process that was linear during the ﬁrst minute and then reached
saturation indicative of carrier-mediated transport (Fig. 2A). Cell
suspensionswerealsoincubatedwith5to100M[ 14C]SAM,and
uptakewasmeasuredafter30stoestimatethekineticconstantsof
recombinant CTL843 (Fig. 2B). From these data, the calculated
apparentKmvalues(reﬂectingSAMafﬁnityforCTL843)andVmax
values (reﬂecting CTL843 activity) were 5.88  0.11 M and
31.570.09pmolmin1mg1,respectively.Toassesstheroleof
the proton gradient in CTL843 function, ATM915 was pretreated
for 5 minutes with 20 M carbonyl cyanide
m-chlorophenylhydrazone (CCCP), which acts as a channel
through the inner membrane to dissipate the H gradient. CCCP
treatment reduced [14C]SAM intracellular uptake by 50%.
SAH is a possible substrate for recombinant CTL843. The
speciﬁcity of CTL843 for SAM was determined by measuring the
effect of structurally related derivatives on SAM transport. Com-
petitionstudieswereperformedinthepresenceofa10-foldexcess
of unlabeled putative competitive inhibitors (Table 2). As ex-
pected, addition of excess cold SAM competed for binding and
uptakeof[14C]SAMininducedATM915cells.Whileweobserved
a slight increase in SAM uptake in the presence of methionine or
homocysteine, only SAH, the molecule formed during the course
of SAM-dependent methylation reactions, strongly inhibited
SAM uptake. Other structural analogs (adenosine, MTA [formed
from SAM during spermidine synthesis], and sinefungin [a syn-
thetic analog of SAH]) had negligible effects on the ability of
CTL843 to transport SAM. The uptake of [14C]SAM was mea-
suredinthepresenceofvariousconcentrationsofSAHtoestimate
the apparent Ki value of SAH for CTL843, which was determined
to be 4.12 M.
Intheabsenceofacommerciallyavailablesourceofradioactive
SAH to follow the direct transport of SAH by CTL843 (see the
supplemental material), we utilized a genetic assay instead. Ele-
vated levels of SAH are toxic for cells, and loss of pfs (which en-
codes the MTA/SAH nucleosidase responsible for detoxiﬁcation
of both MTA and SAH in E. coli) leads to diminished bacterial
growth (7, 17). Although this pfs phenotype was relatively un-
stable, based on the high-frequency (i.e., ~105), spontaneous ap-
pearance of mutants with ﬁtness comparable to that of the wild-
type strain, ﬁrst-passage colonies formed when the pfs::kan
mutation was transduced into MG1655 (see Text S1 in the sup-
plemental material) were always about 60% larger in diameter in
the strain expressing CTL843 (ATM988, Table 1), indicating that
the chlamydial transporter offered an immediate ﬁtness advan-
TABLE 1 Bacterial strains and plasmids
Strain or plasmid Genotype/description Reference or source
E. coli strains
DH5 F 80 (lacZY-argF)U169 deoR recA1 endA1 phoA
hsdR17 supE44  thi-1 gyrA96 relA1 (lacZ)M15
54
MG1655 F  ilvG rfb-50 rph-1 E. coli Genetic Stock Collection
MC4100 F araD139 (argF-lac)U169 rpsL150 relA1 deoC1 rbsR
fthD5301 fruA25 
55
BW25113 (araD-araB)567 lacZ4787 (::rrnB-3)  rph-1 (rhaD-
haB)568 hsdR514
56
ATM609 BW25113 transformed with pKD46 56
ATM770 metK::kan/pREF71 Allelic exchange mutant of ATM609/pREF71
ATM777 MC4100/pREF73 Cmr transformant of MC4100 with pREF73
ATM778 metK::kan/pREF73 Kmr transductant of ATM777 with P1 grown on ATM770
NC13 MC4100 pfs(8-226)::kan 17
ATM1113 metK::kan/pREF73/pREF77 Apr transformant of ATM778 with pREF77
ATM1114 metK::kan/pREF73/pRAK368 Apr transformant of ATM778 with pRAK368
ATM1115 MG1655 pfs::kan Kmr transductant of MG1655 with P1 grown on NC13
ATM915 MG1655/pRAK368 Apr transformant of MG1655 with pRAK368
ATM1116 pfs::kan/pRAK368 Kmr transductant of ATM915 with P1 grown on NC13
ATM1117 metK::kan/pREF73/pUC18 Apr transformant of ATM778 with pUC
Plasmids
pKD46 Para gam bet exo oriR101 repA101(Ts); Apr 56
pAM238 IPTG-inducible expression vector; Spcr;
pSC101 derivative; low copy number
57
pREF71 pAM238::AUG-metKEc This work
pBAD33 Arabinose-inducible expression vector; Cmr;
p15A derivative; low copy number
58
pREF73 pBAD33::GUG-metKEc This work
pCtL2 10-fold coverage of C. trachomatis serovar L2 genome,
2.2-kb average insert size; Apr; pUC19 derivative,
500–700 copies per cell
3
pREF77 pUC19::ctl843Ct; isolate 9 This work
pGEMT PCR cloning vector; Apr; high copy number Promega
pRAK367 pGEMT::lacIq This work
pBluescript II SK() IPTG-inducible expression vector; Apr;
pUC derivative; 300–500 copies per cell
Stratagene
pRAK368 pBluescript II SK()::samhtCt lacIq This work
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the growth phenotype in ATM988 likely reﬂects the ability of
CTL843 to recognize and export SAH out of the cells and the
inability of CTL843 to recognize MTA (Table 2) and is consistent
with the data indicating that SAH is a competitive inhibitor of
SAM transport.
Recombinant CTL843 mediates speciﬁc counterexchange of
SAMwithSAMandSAH.InordertofurthercharacterizeCTL843
as an SAM/SAH antiporter, back-exchange studies were per-
formed. Cultures of ATM915 expressing CTL843 were preloaded
with labeled SAM, washed to remove external radioactivity, and
resuspended in M9 minimal salts supplemented with putative
counterexchange substrates at a 10-fold excess over labeled SAM
andincubatedat37°C.After10min,thecellswerecentrifugedand
radioactivity was counted in the cells and in the supernatant.
Quantiﬁcationofexportedradioactivityallowsdifferentiationbe-
tween counterexchange and unidirectional transport. E. coli ex-
pressing CTL843 and preloaded with [14C]SAM released signiﬁ-
cant amounts of internal label (~80% of the initial amount) after
resuspension in buffer medium supplemented with unlabeled
SAM (thus, against the SAM concentration gradient) or SAH.
CCCP treatment did not affect the counterexchange of labeled
SAM with SAM or SAH (Fig. 3), indicating that exchange of in-
ternal SAM with external SAM or SAH in excess was energy inde-
pendent. On the other hand, maintenance of the cellular SAM
gradient observed in the absence of “competitors” required an
intact proton motive force, as SAM concentration reached equi-
librium across the membranes in the presence of CCCP (Fig. 3).
Thus, CTL843 is active in both directions and can function as an
active symporter or energy-independent antiporter (SAM uptake
coupled to labeled SAM exit). The similitude between SAM and
SAH in the ability to promote the efﬂux of labeled SAM from the
cells strongly suggests that SAH is also being transported into the
cells in exchange for SAM. Consequently, we propose that
CTL843 be renamed C. trachomatis L2 SAMHT for SAM/SAH
transporter.
ComparativeanalysisofSAMHT.AnORFsimilartoCTL843
was found in all genome sequences available for the order Chla-
mydiales, with amino acid identity of 90% for Chlamydia ho-
mologs, 60 to 67% for Chlamydophila homologs, and 34 to 38%
FIG 1 Growth of E. coli metK mutant in the presence or absence of extra-
cellularSAM.ATM778(metK)transformedwiththeindicatedplasmidswas
grownat37°CinLBsupplementedwithAp,Cm,0.2%glucose(solidlines),or
0.2% arabinose (dotted lines), in the absence (A) or presence (B) of 1 mM
SAM.Absorbance(OD600)wasmeasuredinaBioscreengrowthcurveanalyzer
and plotted against time (hours). Error bars represent the standard deviations
from four replicates. Symbols: Œ, pUC-empty vector; □, pREF77-ctl843;,
pRAK368-ctl843;, pRAK368-ctl843 with IPTG.
FIG 2 Kinetics of SAM transport in E. coli. (A) Time course of [14C]SAM
uptakeinE.coliat37°Casafunctionoftime.Thetimecourseassaywascarried
out in transport buffer supplemented with 10 M[ 14C]SAM. Time point
assays were done in triplicate. (B) Effect of substrate concentration on
[14C]SAM uptake at 37°C. The data represent six independent experiments
doneintriplicate.ThebackgroundtransportseenwithMG1655(Œ)wassub-
tractedfromthetransportseenwithATM915(MG1655expressingctl843[])
with GraphPad Prism software, and then nonlinear regression analysis was
performed to obtain the Km and Vmax values.
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duplication of the evolutionarily conserved domain EamA, also
known as DUF6 (PF00892; http://pfam.sanger.ac.uk/family
/PF00892). While EamA is a signature for transporters belonging
to the drug and metabolite transporter (DMT) superfamily, the
presence of two EamA domains further subclassiﬁes these chla-
mydial ORFs in the drug/metabolite exporter (DME) family ex-
hibiting 10 alpha-helical transmembrane spanners (TMSs) (http:
//www.tcdb.org). Interestingly, this family of transporters also
contains the SAM transporters belonging to Rickettsieae, another
group of obligate intracellular bacteria. However, Rickett-
sia prowazekii RP076 (15) shares only about 20% identity with
C. trachomatis L2 CTL843 (Fig. 4). Additional phylogenetic anal-
ysis failed to support any evolutionary relationship between the
rickettsial and the chlamydial SAM transporters (Fig. S5).
DISCUSSION
Bacterial evolution toward obligate intracellular parasitism in a
eukaryotic host is thought to be associated with loss of genetic
information, especially for genes that become redundant within
thehostniche(18).Theselossesarenotdeleteriousfortheorgan-
ism provided that the missing genes, such as those encoding bio-
synthetic functions, can be compensated for by an increased rep-
ertoire of transport functions that allow the organism access to
essential nutrients in the intracellular environment. In this work,
TABLE 2 Effect of putative inhibitors on SAM uptake by E. coli ATM915 expressing CTL843
Unlabeled SAM analoguesa Molecular structure Change (%)b
S-Adenosyl-L-methionine (SAM) 74  8
S-Adenosyl-L-homocysteine (SAH) 84  10
5=-Deoxy-5=-(methylthio)adenosine (MTA) 15  5
Adenosylornithine (sinefungin) 10  13
L-Adenosine 6  8
L-Homocysteine 23  5
L-Methionine 32  9
a One hundred micromolar of the unlabeled compound.
b Change in radioactivity observed in presence of unlabeled compound compared to control with only 10 M[ 14C] SAM.
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matis transporter, CTL843, for the metabolites SAM and likely
SAH. We propose that CTL843 and its respective Chlamydia ho-
mologs be named SAMHT to clarify their role as a SAM and pos-
sible SAH transporter.
Ourattemptstogeneticallycomplementan E.colimetKmu-
tant, ATM778, failed to identify a gene in C. trachomatis L2 that
encodes SAM synthetase activity. Complementation of ATM778
with C. trachomatis L2 CTL843 ORF was dependent on the pres-
ence of extracellular SAM and was related to the expected level of
expression in the cells (compared to pRAK368, pREF77 is ex-
pected to yield 200 extra copies per cell during replication).
CTL843 allows SAM to enter cells, therefore bypassing the E. coli
membranepermeabilitybarrierforSAM.Asimilareffecthasbeen
reportedpreviouslyfortheRickettsiaprowazekiiSAMtransporter
(14, 15). However, this transporter shares only ~20% amino acid
homology with CTL843. In addition, we showed that C. tracho-
matis L2 CTL843 expression partially complemented the growth
defect of an E. coli pfs mutant lacking MTA/SAH nucleosidase
activity, suggesting that recombinant CTL843 was able to reduce
the internal buildup of toxic SAH in the mutant cells. Whole-cell
transport assays further supported CTL843 as a transporter for
SAM and SAH: (i) uptake of [14C]SAM into recombinant E. coli
cells was saturable, exhibiting kinetic constants indicative of a
high-afﬁnity carrier with a Km value below 6 M; (ii) uptake of
[14C]SAM was speciﬁcally inhibited by SAH at an equivalently
high afﬁnity; and (iii) internal [14C]SAM was expelled out of re-
combinant cells in the presence of extracellular SAM or SAH fol-
lowing a countertransport mechanism. Although we were unable
to monitor direct transport of SAH in E. coli cells expressing
CTL843duetothelackofcommerciallyavailablelabeledSAHand
tothelimitofdetectionofSAHbyhigh-performanceliquidchro-
matography (HPLC) (see Text S1 in the supplemental material),
webelievethatourgeneticandbiochemicaldatastronglysupport
the idea that both SAH and SAM are substrates for C. trachomatis
L2 CTL843.
Unlikerickettsiae,chlamydiaemultiplyinthecytoplasmofthe
host cell inside a specialized compartment termed an inclusion.
Because the inclusion membrane is permeable to molecules
smallerthan520Da(19),SAH(384.4Da)andSAM(399.4Da)are
expectedtodiffusefreelybetweenthehostcytoplasmandthebac-
teriaexpressingSAMHT.ThepIvalueofSAMis7.24,andSAHis
neutral between pI values of 3.5 and 9.2 (20). Consequently, both
moleculesareneutralinthemammaliancellcytoplasmandinthe
chlamydial inclusion, where the pH values are calculated to be
7.29  0.07 and 7.25  0.19, respectively (21). Although the glu-
cosepresentinthetransportassaywasprobablypartiallycompen-
sating for the deleterious effect of CCCP on membrane potential
(22),westillobservedinhibitionofSAMimportinE.coliexpress-
ing SAMHT in the presence of CCCP. This shows that C. tracho-
matis L2 SAMHT acts as a secondary active symporter for SAM,
similarly to the rickettsial SAM transporter (15). Conversely, ex-
change of internal SAM with external SAM or SAH is not affected
byCCCPandisthereforeenergyindependent(Fig.3).Thismech-
anismofantiporttransportdrivenbytheinwardsubstrate(SAM)
gradient and the outward product (SAH) gradient is most favor-
ableforthechlamydiae,whichareenergyparasites(23).Asimilar
transportmechanismhasbeendescribedfortheE.coliputrescine-
FIG3 Efﬂuxof[14C]SAMfromE.colicellsexpressingCTL843.Preloadingof
labeled SAM (10 M) in ATM915 was performed initially for 1 min at 37°C
andthenstoppedbydilutionandwashesat4°C.Sampleswereresuspendedin
duplicateinM9minimalsaltswithorwithout100McoldSAMorcoldSAH
and incubated at 37°C in the presence or absence of 20 M CCCP. After
10min,thepartitionoflabeledSAMwasdeterminedbycountingradioactivity
in the supernatants and in the pellets after centrifugation at 13,000 rpm for
90 s.
FIG4 SequencealignmentsofC.trachomatisL2CTL843andR.prowazekiiRP076SAMtransporter.Aminoacidsequenceswereﬁrstalignedonawebinterface
of MAFFT (53) and were subsequently aligned via Clustal W2 to illustrate the similarity. Identical residues are denoted with an asterisk and are highlighted in
black boxes. Strongly conserved residues and weakly conserved residues are marked with a colon and a period, respectively, and are displayed in gray boxes.
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resultoftheantiportactivitybetweenputrescineandornithine,in
an energy-independent manner, and can also catalyze putrescine
uptake in a process that is energy dependent without excretion of
ornithine (24).
Although SAM transporters have been found so far in four
evolutionarily diverse transporter families, identiﬁcation of SAM
carriers using sequence similarity is of limited value because their
degree of homology inside a family is generally not much higher
than that between the different members of the same family. In
Saccharomyces cerevisiae (25), humans (26), and plants (27, 28),
members of the well-characterized mitochondrial carrier protein
(MCP) family (29) transport external SAM in counterexchange
with SAM or SAH with less afﬁnity. In Saccharomyces cerevisiae
(30) and Leishmania (31), transporters belonging to the amino
acid permease superfamily or to the folate biopterin transporter
family, respectively, seem more speciﬁc to SAM, with afﬁnities in
the nanomolar ranges. Like the rickettsial SAM transporter (15),
the chlamydial SAMHT homologs to CTL843 belong to the drug/
metabolite exporter (DME) family (32) and appear to transport
both SAM and SAH with afﬁnities in the micromolar range. Note
that we hypothesize that SAH is also a substrate for the rickettsial
SAM transporters, based on the inhibition of SAM uptake ob-
served in the presence of SAH (15) and the apparent lack of SAH
hydrolasehomologsintheirgenomes(datanotshown).Although
the DME family was recognized 10 years ago and now has 500
sequenced members in bacteria and archaea (33), only three ad-
ditional transporters from E. coli have been functionally charac-
terized to date (34–36), and the molecular mechanisms driving
the activity of DME transporters are not known. The growth de-
pendenceoftheE.colimetKmutantontheactivityofSAMHTin
the presence of SAM might be the ideal platform to screen for
antimicrobial compounds targeting this transport system. In ad-
ditiontoimprovingourknowledgeonthemodeofactionofDME
transporters, SAMHT inhibitors may well lead to the develop-
ment of a new antichlamydial speciﬁc therapy.
The 40 chlamydial species, identiﬁed mostly by 16S rRNA se-
quencing, are classiﬁed into seven families (37, 38), among which
theChlamydiaceae(includingC.trachomatis)arethemoststudied
due to their importance in human and veterinary medicine. Nev-
ertheless, “Chlamydia-like” organisms have been receiving more
attention lately, in particular those residing in free-living amoe-
bae, since an intraprotozoal lifestyle has likely contributed signif-
icantly to the adaptation of intracellular bacterial pathogens to
higher eukaryotes (39–42). Escobar-Páramo et al. (43) suggested
that “ancient” genes will not persist if they do not carry a “lasting
adaptive value” to populations. The presence of a CTL843
SAMHT homolog in the nine Chlamydiaceae representatives and
the three “Chlamydia-like” organisms that have been sequenced
suggests that SAMHT confers adaptive functions that allow the
exploration of new niches such as mammalian cells. Since an ob-
ligateintracellularlifestylelimitsthechanceofgeneacquisitionby
horizontal gene transfer, SAMHT may have initially been ac-
quired by an ancestral, facultative intracellular form of Chla-
mydia. Subsequently, the constant supply of metabolites (i.e.,
SAM)fromthehostrelaxedtheselectivepressuretomaintainthe
metabolic pathways involved in SAM synthesis (MAT) and SAH
degradation(MTANorSahH)andresultedinthecompletelossor
pseudogenization of these genes in all Chlamydiaceae and in
P. amoebophila UWE25, respectively.
The isolated asexual reproductive cycle of Chlamydia and the
evolutionary bottleneck observed at each transmission or passage
to a new host are expected to favor the process of genome degra-
dation (44, 45). Moreover, considering that MAT requires ATP
and that chlamydiae parasitize their host for ATP (46), loss of
MAT is expected to make the microbe more ﬁt in its interaction
with the host and MAT could therefore be under strong pathoad-
aptivepressure(47).Consequently,itissomewhatsurprisingthat
thetwoemergingpathogens(18,48)W.chondrophilaandP.acan-
thamoebae have maintained apparently functional MAT and
SahH enzymes. In the absence of a genetic system to test the con-
tribution of the three genes to bacterial ﬁtness, we do not know if
this reﬂects a greater need for metabolic versatility, a more effec-
tive selection for the maintenance of weakly beneﬁcial genes, or
simply a less advanced stage in the process of the reductive evolu-
tionoftheirgenomes(49).Theanswerstothesequestionswilladd
to a better understanding of the adaptive evolution of Chlamydia
towards pathogenicity.
MATERIALS AND METHODS
Bacterialstrainsandplasmids.Escherichiacolistrainsandplasmidsused
inthisstudyarelistedinTable1,andtheirconstructionisdescribedinthe
supplemental material. E. coli strain DH5 was used for cloning. Strains
were grown in Luria-Bertani (LB) broth with aeration or on LB agar,
unless indicated otherwise. Medium was supplemented with ampicillin
(Ap; 50 g/ml), kanamycin (Km; 50 g/ml), chloramphenicol (Cm;
10 g/ml), spectinomycin (Spc; 100 g/ml), arabinose (0.2%), glucose
(0.5%),isopropyl--D-1-thiogalactopyranoside(IPTG;1mM),andman-
nitol (0.5%) as needed.
Whole-cell transport assays. (i) SAM import. Whole-cell transport
assays were performed as described in references 14 and 50 with slight
modiﬁcations. Overnight LB cultures of MG1655 or ATM915 (Table 1)
weresubcultured1:100into20mlLBsupplementedwithIPTGtoinduce
expression of CTL843 (plus appropriate selective agents as needed) and
grown at 37°C with shaking to mid-log phase (optical density at 600 nm
[OD600] of ~0.7). Cultures were standardized to an OD600 of 0.5 and
concentrated to 2  109 bacteria/ml. Cells were centrifuged and washed
with M9 minimal salts (51). Washed cells were suspended in cold M9
minimal salts plus 0.5% glucose (i.e., transport buffer), yielding approxi-
mately0.6to0.8mg/mltotalproteinandabout1108bacteriaper50-l
reaction mixture. A 10 M concentration of S-adenosyl-L-[methyl-
14C]methionine ([14C]SAM) (GE Healthcare UK Limited) was added to
the bacterial suspension for a ﬁnal volume of 60 l per reaction mixture,
and uptake was initiated at 37°C and followed up to 5 min. Samples were
periodically removed, transferred to 20 ml ice-cold M9 minimal salts to
stop transport, ﬁltered through a 0.45-m Durapore membrane ﬁlter
(Millipore Corp.), and washed once with the same buffer. Filters were
placed in scintillation vials, and radioactivity was measured using 5 ml of
ReadySafe liquid scintillation cocktail (Beckman Coulter).
Disintegration-per-minute values determined by sample counting were
normalizedtotheactivityof[14C]SAM(55mCi/mmol)andtotheprotein
concentration of the sample to express counts as pmol SAM · min-
ute1 · mg total protein1.
Kineticanalysiswasaccomplishedbyincubatingcellsuspensionswith
increasing concentrations of [14C]SAM for 30 s. Data were plotted in
Prism 4 (GraphPad Software), and apparent Km and Vmax values were
determined using the included Michaelis-Menten linear regression tem-
plate. To examine the dependence of SAM transport on membrane po-
tential, samples were pretreated with 20 M carbonyl cyanide
m-chlorophenylhydrazone (CCCP) for 5 minutes prior to the start of the
transport assay. All uptake data are the results of experiments performed
in triplicate unless otherwise indicated.
(ii) SAMHTCt speciﬁcity. The substrate speciﬁcity of recombinant
CTL843 was assessed by measuring the capacity of nonradioactive effec-
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by E. coli strain ATM915. Values obtained from 5 min of preincubation
with100Meffectorswereexpressedaspercentinhibitionrelativetothe
absence of inhibitor (15, 50). Additionally, the dissociation constant for
the binding of SAH to CTL843 (i.e., Ki value) was determined by two
methods using Prism 4 software. First, the kinetics of SAM uptake were
determinedinthepresenceof5and20McoldSAH.Second,theKivalue
of SAH was calculated from the half-maximal inhibitory concentration
(IC50)estimatedbyiterativecurveﬁttingforsigmoidalequationsdescrib-
ing SAM uptake velocity in the presence of 0 to 100 M SAH, using the
equation of Cheng and Prusoff (52).
(iii) Reversibility of SAM transport. To determine the capacity of
recombinant CTL843 to transport SAM in two directions, induced cells
were incubated with 10 M[ 14C]SAM for 1 min at 37°C to allow for
uptake of labeled SAM and then washed twice in 25 ml cold M9 minimal
salts and resuspended in transport buffer to a density of 1  109 bacteria/
100lofbacterialsuspension.NonradioactiveSAMorSAHwasaddedto
100 l of bacteria to a ﬁnal concentration of 100 M and incubated at
37°C. Reactions were stopped after 10 min by centrifugation at
13,000rpmfor90s,andradioactivity(disintegration-per-minutevalues)
was measured in the supernatants and the pellets. To examine the depen-
denceofSAMexchangeonmembranepotential,sampleswerepretreated
with20MCCCPfor5minutespriortoadditionofthecoldcompetitive
inhibitors. The two independent experiments performed showed the
same trend.
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